The investment positions Tether as the majority stakeholder in the biotech firm renowned for its advancements in brain-computer interface (BCI) technology.
Jerrymusa.com reports that the funds will enhance Blackrock Neurotech’s ability to commercialise its medical tools and further its research and development initiatives.
Following Tether’s announcement of a record-breaking $2.9 billion net profit for the fourth quarter of 2023, the investment was made.
The Power Of Crypto-AI Technology
“With Tether Evo, Blackrock Neurotech is just the start of our journey into projects that redefine the boundaries of what’s possible at the intersection of technological innovation and human potential,” said Ardoino. Blackrock’s technology is intended to improve cognitive, communication, and rehabilitation abilities.
Blackrock Neurotech, a pioneer in brain-computer interface technology, was founded in 2008 and helps people with neurological conditions and paralysis operate gadgets with their minds.
Using this technology in 2016, Nathan Copeland communicated with former US President Barack Obama.
Blackrock Neurotech’s co-founder, Dr. Florian Solzbacher, believes that Tether’s collaboration is essential to the advancement of medical technology.
Tether is branching out beyond stablecoins with this investment through its Tether Evo division.
In an effort to combine technology and human potential, the firm has formed other divisions, including Tether Data, Tether Finance, Tether Power, and Tether Education.